Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Israel
Israel: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 94.0% in 2024. ▬ Flat
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Israel, 2011–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
The most recent figure for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Israel is 94.0%, measured in 2024.
Compared with earlier readings it is unchanged over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Israel peaked at 95.0% in 2018 and was at its lowest, 92.0%, in 2011.
Israel ranks 34th of 146 countries on this measure, in the top quarter.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Israel, year by year
| Year | % | Change |
|---|---|---|
| 2011 | 92.0% | — |
| 2012 | 93.0% | +1.1% |
| 2013 | 94.0% | +1.1% |
| 2014 | 94.0% | +0.0% |
| 2015 | 94.0% | +0.0% |
| 2016 | 93.0% | -1.1% |
| 2017 | 94.0% | +1.1% |
| 2018 | 95.0% | +1.1% |
| 2019 | 95.0% | +0.0% |
| 2020 | 94.0% | -1.1% |
| 2021 | 95.0% | +1.1% |
| 2022 | 94.0% | -1.1% |
| 2023 | 94.0% | +0.0% |
| 2024 | 94.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 93.8% | 92.0% | 95.0% | 9 |
| 2020s | 94.2% | 94.0% | 95.0% | 5 |
Countries ranked near Israel
- 34 Armenia 94.0% compare
- 34 Barbados 94.0% compare
- 34 Belgium 94.0% compare
- 34 Russian Federation 94.0% compare
- 34 Seychelles 94.0% compare
- 34 Sweden 94.0% compare
- 34 United Arab Emirates 94.0% compare
- 34 Uzbekistan 94.0% compare
More health data for Israel
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6956 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 665.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 119 deaths (2100)
- Population ages 0-14, female, annual growth rate 0.2922 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1323 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.3071 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1394 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Israel?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Israel was 94.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Israel?
- The highest recorded value was 95.0% in 2018.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Israel?
- The lowest recorded value was 92.0% in 2011.
- How does Israel rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Israel ranks 34th out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Israel?
- Over the last ten years it is unchanged. The long-run trend across the full record is flat.
- Where does this Israel data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 14 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.